[P3–217]: NOVEL BIOMARKER P3‐ALCα, PEPTIDES PRODUCED BY γ‐SECRETASE CLEAVAGE, ALTERED IN AD PATIENTS
Alzheimer's & Dementia, 2017Chiori Omori +4 more
openaire +1 more source
P3–352: APLP1–derived peptides do not undergo rapid fibrillogenesis
Alzheimer's & Dementia, 2006Aedin M. Minogue +5 more
openaire +1 more source
P3‐343: Homocysteine inhibits the enzymatic degradation of Aβ peptide
Alzheimer's & Dementia, 2008Javier Pacheco-Quinto +2 more
openaire +1 more source
Derivatization with fatty acids in peptide and protein drug discovery
Nature Reviews Drug Discovery, 2022Peter Kurtzhals +2 more
exaly
P3‐306: Anti‐aggregation peptide/peptoid chimeric oligomers exhibiting neuroprotective effects
Alzheimer's & Dementia, 2010Martin J. Sadowski +6 more
openaire +1 more source
P3–337: Enhancement of neurogenesis by peptides: A promising therapeutic approach
Alzheimer's & Dementia, 2006Inge Grundke-Iqbal +4 more
openaire +1 more source
Trends in peptide drug discovery
Nature Reviews Drug Discovery, 2021Markus Muttenthaler +2 more
exaly
P3‐314: Prevention of amyloid β‐peptide fibrillation by the BRICHOS domain
Alzheimer's & Dementia, 2011Jenny Presto +6 more
openaire +1 more source
P3‐037: THE B‐AMYLOID PEPTIDE COMPROMISES REELIN SIGNALING IN ALZHEIMER'S DISEASE
Alzheimer's & Dementia, 2014Inmaculada Cuchillo‐Ibañez +3 more
openaire +1 more source
P3‐355: Oligomeric beta‐amyloid peptide stimulates a unique microglial activation phenotype
Alzheimer's & Dementia, 2008Colin K. Combs +2 more
openaire +1 more source